Abstract

Large-scale radiation emergency scenarios involving protracted low dose rate radiation exposure (e.g. a hidden radioactive source in a train) necessitate the development of high throughput methods for providing rapid individual dose estimates. During the RENEB (Running the European Network of Biodosimetry) 2019 exercise, four EDTA-blood samples were exposed to an Iridium-192 source (1.36 TBq, Tech-Ops 880 Sentinal) at varying distances and geometries. This resulted in protracted doses ranging between 0.2 and 2.4 Gy using dose rates of 1.5–40 mGy/min and exposure times of 1 or 2.5 h. Blood samples were exposed in thermo bottles that maintained temperatures between 39 and 27.7 °C. After exposure, EDTA-blood samples were transferred into PAXGene tubes to preserve RNA. RNA was isolated in one laboratory and aliquots of four blinded RNA were sent to another five teams for dose estimation based on gene expression changes. Using an X-ray machine, samples for two calibration curves (first: constant dose rate of 8.3 mGy/min and 0.5–8 h varying exposure times; second: varying dose rates of 0.5–8.3 mGy/min and 4 h exposure time) were generated for distribution. Assays were run in each laboratory according to locally established protocols using either a microarray platform (one team) or quantitative real-time PCR (qRT-PCR, five teams). The qRT-PCR measurements were highly reproducible with coefficient of variation below 15% in ≥ 75% of measurements resulting in reported dose estimates ranging between 0 and 0.5 Gy in all samples and in all laboratories. Up to twofold reductions in RNA copy numbers per degree Celsius relative to 37 °C were observed. However, when irradiating independent samples equivalent to the blinded samples but increasing the combined exposure and incubation time to 4 h at 37 °C, expected gene expression changes corresponding to the absorbed doses were observed. Clearly, time and an optimal temperature of 37 °C must be allowed for the biological response to manifest as gene expression changes prior to running the gene expression assay. In conclusion, dose reconstructions based on gene expression measurements are highly reproducible across different techniques, protocols and laboratories. Even a radiation dose of 0.25 Gy protracted over 4 h (1 mGy/min) can be identified. These results demonstrate the importance of the incubation conditions and time span between radiation exposure and measurements of gene expression changes when using this method in a field exercise or real emergency situation.

Highlights

  • Allowed for the biological response to manifest as gene expression changes prior to running the gene expression assay

  • Even a radiation dose of 0.25 Gy protracted over 4 h (1 mGy/min) can be identified. These results demonstrate the importance of the incubation conditions and time span between radiation exposure and measurements of gene expression changes when using this method in a field exercise or real emergency situation

  • The expression of several genes has already been shown to be modulated in a dose-dependent ­manner[4,5,6] and there is strong evidence for gene expression to be used as an alternative tool for e­ arly[7,8], highthroughput minimally invasive radiation ­biodosimetry[9,10,11,12,13,14] and point of care d­ iagnostic[15]

Read more

Summary

Introduction

Allowed for the biological response to manifest as gene expression changes prior to running the gene expression assay. The method is sensitive and very ­reliable[2], but it is time consuming and requires several days (lymphocytes in G0 phase have to be stimulated to re-enter the cell cycle where they will be arrested in the metaphase in vitro) before the dose estimates are ­available[3] Another emerging technique is based on gene expression analysis observed after radiation exposure. Astronauts on a mission to Mars represent another scenario in which scientists are concerned about haematopoetic responses, cancers, neurological and cardiovascular ­damage[31] and for which reliable biological dose and risk estimation is highly desirable Motivated by these protracted low dose rate scenarios a study was organized in 2019 and performed jointly under the umbrella of the RENEB e.V. network (Running the European Network of Biological dosimetry and physical retrospective dosimetry) together with the EURADOS Working Group (WG) 10 Retrospective Dosimetry. This study adds to several questions such as the impact of dose rate on gene expression changes performed in different laboratories worldwide as well as the reproducibility and the required degree of protocol harmonization inherent to transcriptomic analysis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call